MYC and ischemic stroke: To further validate candidate berberine targets in ischaemic stroke, we tested the precision of docking between berberine and the following potential target proteins: MAPK8, JUN, EGFR, STAT3, MAPK1, SRC, MAPK14, MAPK3, AKT1, and MYC.